Clinical Trials Directory

Trials / Completed

CompletedNCT03184701

Monitoring of Symptoms and Cognitive Function Using Telehealth

Remote Monitoring of Symptoms and Cognitive Function Using Telehealth

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Albert Einstein Healthcare Network · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

End-Stage Liver Disease (ESLD) is one of the ten leading causes of death in US. It is marked by episodic acute exacerbations of the underlying liver disease which often leads to severe symptoms, poor quality of life, mental deterioration and repeated hospitalizations. The overall purpose of this project is to introduce a telehealth based intervention (involving remote monitoring of symptoms and cognitive function initiated at the time of discharge of ESLD patients. This will support enhanced clinical care and improve self-management in ESLD population. In addition, it will reduce healthcare utilization, improve medication adherence and overall health outcomes

Detailed description

This is a single arm study to assess the effectiveness of an experimental telehealth intervention within the treatment of ESLD, and compare it with a historic cohort. All inpatients with advanced liver disease and at least 1 complication will be eligible to participate. the study group receives the Telehealth intervention and will be given an ipad preloaded with the instruments used for symptom monitoring and cognitive function assessment during the hospital admission.

Conditions

Interventions

TypeNameDescription
OTHERTelehealthPatients will be given an ipad with preloaded app (secured questions assessing their symptoms and cognitive function in a systematic timely way). The responses will be delivered to the care providers instantly, which will trigger an algorithmic clinical approach.

Timeline

Start date
2016-04-30
Primary completion
2018-08-30
Completion
2018-08-30
First posted
2017-06-14
Last updated
2020-04-17
Results posted
2020-04-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03184701. Inclusion in this directory is not an endorsement.